FFilingSight

CME Group Inc. (CME) 10-K Red Flags

Risk signals extracted deterministically from CME Group Inc.’s SEC 10-K/10-Q XBRL filings — no LLM, every finding cites the underlying data.

Detected red flags (10)

  • Restatement of financial statements: The term "restatement of" "previously issued" appears in 1 recent filing(s) (vs 1 in the prior period). This risk language is ongoing.
  • Deferred revenue growing — future revenue visibility: Deferred revenue grew +259.2% to $17.6M, providing forward revenue visibility. This is a positive leading indicator for subscription or contract-based businesses.
  • Endogenous analysis: 1 positive signal(s) versus 1 risk signal(s). The filing exhibits more constructive indicators than concerns, though individual risk factors should still be monitored.
  • 20 new XBRL disclosure(s) in latest filing — expanding reporting scope.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
  • Ongoing high-severity risk language: Restatement of financial statements.
  • Composite risk: Elevated.
  • Liquidity current ratio 1.02 (adequate).
  • Restatement of financial statements: The term "restatement of" "previously issued" appears in 1 recent filing(s) (vs 1 in the prior period). This risk language is ongoing.
  • Deferred revenue growing — future revenue visibility: Deferred revenue grew +259.2% to $17.6M, providing forward revenue visibility. This is a positive leading indicator for subscription or contract-based businesses.

Filings & ownership

  • Latest annual report (10-K) filed Feb 26, 2026.
  • Latest quarterly report (10-Q) filed Jul 24, 2026.
  • 13 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 0 sell transactions.

Full CME analyst report

Valuation (DCF & Graham), technicals, macro exposure, risk scorecard and 13F/13D ownership.

View full report →

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.